AR005347A1 - Compuestos 4,5-di-hidronaf[1,2-c]isoxasoles, derivados y composiciones farmaceuticas, metodo de preparacion, uso como substancia farmaceuticamenteactiva y usos para la fabricacion de medicamentos para el tratamiento de la ansiedad, alteraciones psiquiatricas, nausea, vomitos, dependencia de farmacos - Google Patents
Compuestos 4,5-di-hidronaf[1,2-c]isoxasoles, derivados y composiciones farmaceuticas, metodo de preparacion, uso como substancia farmaceuticamenteactiva y usos para la fabricacion de medicamentos para el tratamiento de la ansiedad, alteraciones psiquiatricas, nausea, vomitos, dependencia de farmacosInfo
- Publication number
- AR005347A1 AR005347A1 ARP970100015A ARP970100015A AR005347A1 AR 005347 A1 AR005347 A1 AR 005347A1 AR P970100015 A ARP970100015 A AR P970100015A AR P970100015 A ARP970100015 A AR P970100015A AR 005347 A1 AR005347 A1 AR 005347A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- pharmaceutical
- hydroxy
- manufacture
- dependence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58331996A | 1996-01-05 | 1996-01-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR005347A1 true AR005347A1 (es) | 1999-04-28 |
Family
ID=24332609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970100015A AR005347A1 (es) | 1996-01-05 | 1997-01-03 | Compuestos 4,5-di-hidronaf[1,2-c]isoxasoles, derivados y composiciones farmaceuticas, metodo de preparacion, uso como substancia farmaceuticamenteactiva y usos para la fabricacion de medicamentos para el tratamiento de la ansiedad, alteraciones psiquiatricas, nausea, vomitos, dependencia de farmacos |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0874833A1 (xx) |
JP (1) | JP3161737B2 (xx) |
KR (1) | KR100308748B1 (xx) |
CN (1) | CN1214046A (xx) |
AR (1) | AR005347A1 (xx) |
AU (1) | AU710059B2 (xx) |
BR (1) | BR9612578A (xx) |
CA (1) | CA2241845C (xx) |
HU (1) | HUP9903706A3 (xx) |
IL (1) | IL125197A0 (xx) |
NO (1) | NO983100L (xx) |
NZ (1) | NZ325587A (xx) |
WO (1) | WO1997025317A1 (xx) |
ZA (1) | ZA9725B (xx) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050131051A1 (en) * | 2000-08-21 | 2005-06-16 | Shaomeng Wang | 2-3-disubstituted quinuclidiness as modulators of monoamine transporters and theraperutic and diagnostic methods based thereon |
CN100349897C (zh) * | 2002-04-02 | 2007-11-21 | 詹森药业有限公司 | 经取代的氨基异唑啉衍生物及其作为抗抑郁药的用途 |
TW200409777A (en) * | 2002-08-12 | 2004-06-16 | Janssen Pharmaceutica Nv | C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants |
ATE456568T1 (de) | 2002-08-15 | 2010-02-15 | Janssen Pharmaceutica Nv | Kondensierte heterocyclische isoxazolinderivate und deren verwendung als antidepressiva |
ATE387455T1 (de) * | 2002-08-21 | 2008-03-15 | Janssen Pharmaceutica Nv | C6- und c9-substituierte chromeno(4,3- c)isoxazoline und ihre verwendung als anti- depressiva |
US8025859B2 (en) | 2007-05-18 | 2011-09-27 | Cesl Limited | Process for gold and silver recovery from a sulphide concentrate |
MX336881B (es) | 2009-10-29 | 2016-02-04 | Bristol Myers Squibb Co | Compuestos heterociclicos triciclicos. |
EP3507278B1 (en) | 2016-09-02 | 2021-01-27 | Bristol-Myers Squibb Company | Substituted tricyclic heterocyclic compounds |
US11046646B2 (en) | 2017-08-09 | 2021-06-29 | Bristol-Myers Squibb Company | Alkylphenyl compounds |
US11059784B2 (en) | 2017-08-09 | 2021-07-13 | Bristol-Myers Squibb Company | Oxime ether compounds |
KR102002633B1 (ko) | 2018-07-19 | 2019-07-22 | 김태효 | 완충이격부가 구비된 논슬립 발의류 |
KR102429797B1 (ko) | 2019-12-31 | 2022-08-05 | 주식회사 제이패션 | 기능성 무재봉 덧신 및 이를 제조하는 제조방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2119977A1 (en) * | 1971-04-23 | 1971-12-16 | Teikoku Hormone Manufacturing Co , Ltd, Tokio | Antiphlogistic and antisecretory napththisoxazoles - from 1-hydroxyim - 2-carbonyl derivs by intramolecular condensation |
EP0402644B1 (en) * | 1989-05-19 | 1995-08-16 | Hoechst-Roussel Pharmaceuticals Incorporated | N-(aryloxyalkyl)heteroarylpiperidines and -heteroarylpiperazines,a process for their preparation and their use as medicaments |
EP0665840A1 (en) * | 1992-10-23 | 1995-08-09 | MERCK SHARP & DOHME LTD. | Dopamine receptor subtype ligands |
-
1996
- 1996-12-12 CN CN96180175A patent/CN1214046A/zh active Pending
- 1996-12-12 BR BR9612578A patent/BR9612578A/pt not_active Application Discontinuation
- 1996-12-12 NZ NZ325587A patent/NZ325587A/xx unknown
- 1996-12-12 JP JP52519797A patent/JP3161737B2/ja not_active Expired - Fee Related
- 1996-12-12 CA CA002241845A patent/CA2241845C/en not_active Expired - Fee Related
- 1996-12-12 HU HU9903706A patent/HUP9903706A3/hu unknown
- 1996-12-12 EP EP96944274A patent/EP0874833A1/en not_active Withdrawn
- 1996-12-12 IL IL12519796A patent/IL125197A0/xx unknown
- 1996-12-12 KR KR1019980705166A patent/KR100308748B1/ko not_active IP Right Cessation
- 1996-12-12 WO PCT/US1996/019569 patent/WO1997025317A1/en not_active Application Discontinuation
- 1996-12-12 AU AU14126/97A patent/AU710059B2/en not_active Ceased
-
1997
- 1997-01-02 ZA ZA9725A patent/ZA9725B/xx unknown
- 1997-01-03 AR ARP970100015A patent/AR005347A1/es unknown
-
1998
- 1998-07-03 NO NO983100A patent/NO983100L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA9725B (en) | 1997-07-07 |
KR19990077033A (ko) | 1999-10-25 |
IL125197A0 (en) | 1999-03-12 |
JPH11510816A (ja) | 1999-09-21 |
KR100308748B1 (ko) | 2001-12-12 |
NO983100D0 (no) | 1998-07-03 |
CA2241845C (en) | 2002-10-01 |
AU1412697A (en) | 1997-08-01 |
CA2241845A1 (en) | 1997-07-17 |
JP3161737B2 (ja) | 2001-04-25 |
AU710059B2 (en) | 1999-09-09 |
CN1214046A (zh) | 1999-04-14 |
HUP9903706A3 (en) | 2000-09-28 |
NZ325587A (en) | 1999-02-25 |
WO1997025317A1 (en) | 1997-07-17 |
HUP9903706A2 (hu) | 2000-08-28 |
NO983100L (no) | 1998-09-04 |
BR9612578A (pt) | 1999-07-27 |
EP0874833A1 (en) | 1998-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU94031155A (ru) | Амидин - производные, способ их получения, их использование в качестве ингибиторов no - синтазы, фармсостав, способ лечения | |
AR005347A1 (es) | Compuestos 4,5-di-hidronaf[1,2-c]isoxasoles, derivados y composiciones farmaceuticas, metodo de preparacion, uso como substancia farmaceuticamenteactiva y usos para la fabricacion de medicamentos para el tratamiento de la ansiedad, alteraciones psiquiatricas, nausea, vomitos, dependencia de farmacos | |
CY1105035T1 (el) | Συγχωνευμενα με αρυλιο ή ετεροαρυλιο παραγωγα της ιμιδαζολης ως αντιφλεγμονωδεις και αναλγητικοι παραγοντες | |
DK0447285T3 (da) | Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem | |
ES2093399T3 (es) | Nuevos derivados de acido fosfono-succinico, procedimiento para su preparacion y medicamentos que contienen estos compuestos. | |
NO965334L (no) | Nye 4,6-diarylpyrimidin-derivater og salter derav | |
DK151800C (da) | Analogifremgangsmaade til fremstilling af et 2-phenylenmorpholinderivat, herunder dettes optiske isomere, eller et farmaceutisk acceptabelt syreadditionssalt deraf | |
AR008291A1 (es) | Derivados de tetrahidroisoquinolina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y su uso para la preparacionde un medicamento. | |
PT1216245E (pt) | Derivados sulfonil-hidrazida farmaceuticamente activos | |
ES2147749T3 (es) | Procedimiento para la preparacion de derivados de ciano-metoxiiminometilo. | |
AR013152A1 (es) | Derivados de 2-alquilheterodihidropirimidina, proceso para su preparacion, composiciones farmaceuticas que contienen dichos derivados y el uso de dichosderivados y composiciones como ligandos para canales de calcio neuronales de tipo n. | |
ES2183492T3 (es) | Nuevos derivados de nitrono,su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
NO164593C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbamat- eller urea-derivater. | |
MX9405111A (es) | Nuevos derivados de (1-fenil-1-heterociclil)metanol y(1-fenil-1-heterociclil-metilamina). | |
PT1178047E (pt) | Derivados diazabiciclooctano e seus usos terapeuticos | |
JPS6466116A (en) | Antiemetic containing specific substituted phenylalkylamino and amino acid derivatives and compound selected from other serotonin drying drugs | |
DK333380A (da) | Fremgangsmaade til fremstilling af 3-amino-1-benzoxepin-derivater eller syreadditionssalte deraf | |
PT91880A (pt) | Processo para a preparacao de derivados ariloxi-,ariltio-,heteroariloxi- ou heteroariltio-alcenilenicos de aminas e de composicoes farmaceuticas que os contem | |
AR006553A1 (es) | COMPUESTOS ESPIRO[CICLOPENT[b] INDOLPIPERIDINAS] PARTICULARMENTE UTILES PARA ALIVIAR LA DISFUNCION DE LA MEMORIA, INTERMEDIARIOS, COMPOSICIONESFARMACEUTICAS, USOS Y PROCEDIMIENTOS DE PREPARACION DE DICHOS COMPUESTOS. | |
PT82634B (pt) | Processo para a preparacao de novos compostos alcaloides contendo um nucleo berbano uteis como medicamentos | |
IT1304656B1 (it) | Derivati dell'acido retinoico per uso medicinale e relativometodo di preparazione. | |
EA200100344A2 (ru) | Новые циклобутаиндолкарбоксамидные производные, способ их получения и содержащие их фармацевтические композиции | |
CO4230104A1 (es) | Derivados de amina, proceso para su preparacion y composi- cion farmaceutica que los contiene | |
AR034111A1 (es) | Compuestos 7-deazapurinas n-6 sustituidas para receptores de adenosina a1 y a3, un metodo para su preparacion, una prodroga soluble, composicion farmaceutica y usos de los mismos para la manufactura de medicamentos y un metodo para inhibir la actividad de un receptor de adenosina a1 | |
AR009445A1 (es) | Compuestos n-(piridinilamino)isoindolinas y compuestos relacionados, composiciones farmaceuticas, usos en la fabricacion de medicamentos para eltratamiento de la disfuncion de la memoria y la depresion, procedimiento de preparacion de dichos compuestos y compuestos intermediarios |